+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microbiome Diagnostics Market - Global Forecast 2025-2030- Product Image
Microbiome Diagnostics Market - Global Forecast 2025-2030- Product Image
Sale

Microbiome Diagnostics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968243
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Microbiome diagnostics is redefining healthcare by translating microbial profiling into actionable clinical insights and accelerated drug development. Senior decision-makers are increasingly aligning investments and partnerships with the transformative power of advanced assay platforms and integrated analytics, capitalizing on new value pools as the market evolves.

Market Snapshot: Microbiome Diagnostics Market Size and Growth Trends

The Microbiome Diagnostics Market grew from USD 960.27 million in 2024 to USD 1.16 billion in 2025. It is expected to continue growing at a CAGR of 20.86%, reaching USD 2.99 billion by 2030. This significant trajectory highlights robust demand for precision medicine, advanced sequencing technologies, and bioinformatics solutions across global healthcare ecosystems.

Scope & Segmentation

This report examines the breadth and depth of the microbiome diagnostics landscape, with detailed coverage of technologies, clinical areas, and geographic reach.

  • Technology Platforms: Microarray, Next-Gen Sequencing (including 16S rRNA sequencing, shotgun metagenomics, whole genome sequencing), qPCR (digital PCR, real-time PCR).
  • Diagnostic Applications: Disease diagnosis, drug development (biomarker discovery, clinical trials support), personalized nutrition, risk assessment, therapeutic monitoring.
  • Sample Types: Blood, fecal, oral, skin, urine.
  • Indications: Dermatological conditions, gastrointestinal disorders, infectious diseases, metabolic disorders, oncology.
  • End Users: Academic research institutes, diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies.
  • Service Types: Clinical testing services, research services.
  • Components: Consumables (kits and reagents, sample preparation), instruments, software and bioinformatics (cloud platforms, data analysis software, LIMS integration).
  • Geographic Coverage: Americas (with sub-segments including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, multiple others), Asia-Pacific (covered countries include China, India, Japan, and more).
  • Industry Players: Viome, DayTwo, CosmosID, Microba Life Sciences, Diversigen, Microbial Insights, Admera Health, Genova Diagnostics, Omnibiome, BiomeSense.

Key Takeaways for Senior Decision-Makers

  • Rapid advances in sequencing chemistries and digital PCR technologies are enhancing sensitivity and reproducibility, accelerating adoption of microbiome diagnostics in both clinical and research settings.
  • Collaborative partnerships across genomics, bioinformatics, and healthcare are driving integrated platform solutions, resulting in end-to-end workflows from sample collection to actionable reporting.
  • Standardization initiatives by regulatory agencies are creating a more structured environment for product commercialization and facilitating faster time-to-market for validated assays.
  • Broader acceptance of digital and decentralized testing models allows healthcare providers to leverage microbiome data in direct patient care, fostering opportunities for bundled diagnostics and personalized treatment strategies.
  • Competitive differentiation increasingly depends on offering multiomic data integration capabilities and robust software for data interpretation, as stakeholders prioritize value-based outcomes.

Tariff Impact on Supply Chains and Operations

Recently imposed tariffs by the United States on imported instruments, reagents, and consumables have raised operating expenses for diagnostic labs and research facilities. Organizations are reevaluating supplier relationships and exploring domestic manufacturing partnerships to improve resilience. These cost pressures affect R&D investments and are prompting end users to consider alternative workflows to maintain patient access and control expenditure. Strategic supply chain planning and regional sourcing are becoming essential to sustain business continuity and innovation momentum.

Methodology & Data Sources

This report uses a rigorous blend of primary research—interviews with leading scientists, lab directors, and industry executives—and secondary analysis of scientific literature, regulatory filings, and market reports. Findings are verified through source triangulation and subject matter expert review, ensuring robust and actionable strategic intelligence.

Why This Report Matters

  • Enables C-suite leaders to identify high-return technologies and business models tailored to current market dynamics.
  • Supports targeted R&D and investment decisions across clinical adoption, regulatory alignment, and supply chain strategy within the microbiome diagnostics sector.
  • Equips organizations to anticipate market shifts, optimize cross-functional collaborations, and sustain competitive differentiation as the regulatory and real-world evidence landscape progresses.

Conclusion

The microbiome diagnostics sector offers compelling growth through continual platform innovation, evolving regulation, and expanding clinical applications. Strategic alignment with technology, regulatory, and supply trends will empower market leaders to drive long-term value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of AI-powered bioinformatics platforms for rapid microbiome profiling and predictive diagnostics
5.2. Emergence of gut-brain axis microbiome biomarker panels for early detection of neurological disorders
5.3. Expansion of point-of-care microbiome testing devices enabling decentralized screening and patient monitoring
5.4. Integration of multiomic microbiome, metabolomic, and host genomic data to advance precision diagnostics
5.5. Development of standardized reference libraries and workflows to ensure reproducibility in microbiome diagnostics
5.6. Rising consumer interest in at-home stool and saliva microbiome tests for personalized nutrition and wellness guidance
5.7. Strategic partnerships between diagnostic innovators and pharma companies to co-develop microbiome companion diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Microbiome Diagnostics Market, by Technology
8.1. Introduction
8.2. Microarray
8.3. Next-Gen Sequencing
8.3.1. 16S Rrna Sequencing
8.3.2. Shotgun Metagenomics
8.3.3. Whole Genome Sequencing
8.4. Qpcr
8.4.1. Digital Pcr
8.4.2. Real-Time Pcr
9. Microbiome Diagnostics Market, by Diagnostic Application
9.1. Introduction
9.2. Disease Diagnosis
9.3. Drug Development
9.3.1. Biomarker Discovery
9.3.2. Clinical Trials Support
9.4. Personalized Nutrition
9.5. Risk Assessment
9.6. Therapeutic Monitoring
10. Microbiome Diagnostics Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Fecal
10.4. Oral
10.5. Skin
10.6. Urine
11. Microbiome Diagnostics Market, by Indication
11.1. Introduction
11.2. Dermatological Conditions
11.3. Gastrointestinal Disorders
11.4. Infectious Diseases
11.5. Metabolic Disorders
11.6. Oncology
12. Microbiome Diagnostics Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.3. Diagnostic Laboratories
12.4. Hospitals & Clinics
12.5. Pharmaceutical & Biotechnology Companies
13. Microbiome Diagnostics Market, by Service Type
13.1. Introduction
13.2. Clinical Testing Services
13.3. Research Services
14. Microbiome Diagnostics Market, by Component
14.1. Introduction
14.2. Consumables
14.2.1. Kits & Reagents
14.2.2. Sample Preparation
14.3. Instruments
14.4. Software & Bioinformatics
14.4.1. Cloud Platforms
14.4.2. Data Analysis Software
14.4.3. LIMS Integration
15. Americas Microbiome Diagnostics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Microbiome Diagnostics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Microbiome Diagnostics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Viome, Inc.
18.3.2. DayTwo, Inc.
18.3.3. CosmosID, Inc.
18.3.4. Microba Life Sciences Pty Ltd
18.3.5. Diversigen, Inc.
18.3.6. Microbial Insights, LLC
18.3.7. Admera Health LLC
18.3.8. Genova Diagnostics, Inc.
18.3.9. Omnibiome, LLC
18.3.10. BiomeSense Ltd
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MICROBIOME DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. MICROBIOME DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 30. MICROBIOME DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. MICROBIOME DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 32. MICROBIOME DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MICROBIOME DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY FECAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY FECAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SKIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SKIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLOUD PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLOUD PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY LIMS INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY LIMS INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 166. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 167. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 168. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 169. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 172. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 173. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 182. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 183. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 184. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 185. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 186. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 193. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 196. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 197. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 206. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 207. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 208. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 209. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 309. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2024 (USD MILLION)
TABLE 312. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2025-2030 (USD MILLION)
TABLE 313. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2024 (USD MILLION)
TABLE 314. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2025-2030 (USD MILLION)
TABLE 315. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 318. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 319. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 320. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 321. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Microbiome Diagnostics market report include:
  • Viome, Inc.
  • DayTwo, Inc.
  • CosmosID, Inc.
  • Microba Life Sciences Pty Ltd
  • Diversigen, Inc.
  • Microbial Insights, LLC
  • Admera Health LLC
  • Genova Diagnostics, Inc.
  • Omnibiome, LLC
  • BiomeSense Ltd

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.99 Billion
Compound Annual Growth Rate20.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gut Microbiome Testing Service Market - Global Forecast 2025-2030 - Product Image

Gut Microbiome Testing Service Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Microbiome Sequencing Services Market - Global Forecast 2025-2030 - Product Image

Microbiome Sequencing Services Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Microbiome Sample Preparation Technology Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables), Workflow, Application, Disease, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Microbiome Sample Preparation Technology Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables), Workflow, Application, Disease, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Microbiome Analysis Market Size, Share & Trends Analysis Report, By Product & Services (Instruments, Consumables, Services), By Technology (16S rRNA Sequencing, Shotgun Sequencing), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Microbiome Analysis Market Size, Share & Trends Analysis Report, By Product & Services (Instruments, Consumables, Services), By Technology (16S rRNA Sequencing, Shotgun Sequencing), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Human Microbiome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Human Microbiome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 116 Pages
  • Global
From

About the Market

Within the field of biotechnology, the microbiome diagnostics market encompasses a range of technologies and products aimed at analyzing and understanding the complex communities of microorganisms, particularly bacteria and fungi, that inhabit various environments, including the human body. These diagnostics are crucial for advancing the comprehension of the human microbiome and its impact on health and disease. This market leverages advancements in genomics, proteomics, and bioinformatics to identify microbial compositions in different biological samples. The applications of microbiome diagnostics are broad, ranging from identifying dysbiosis associated with disease states to predicting the response to therapeutics and personalizing treatment plans. Microbiome diagnostics play a pivotal role in preventive medicine, nutrition, and the development of targeted therapies by providing insights into the correlation between microbial flora and patient outcomes. The approach has been especially fruitful in the areas of gastrointestinal and metabolic diseases, where the gut microbiome is known to have a major influence. Additionally, the research in this field is rapidly expanding, with discoveries regularly enhancing the potential of microbiome-based diagnostics and therapeutics. Several companies have established themselves in the microbiome diagnostics market, contributing to its growth and innovation. Notable among these are uBiome (now rebranded as BiomeSense), which specializes in microbial genomics for health, disease, and lifestyle; Second Genome, a company that has developed a platform for microbiome science to influence disease treatment and prevention; and CosmosID, which offers microbial genomics solutions for infectious disease diagnostics and microbiome analysis Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.